(Q33473028)

27 July 2017

title

Interim data monitoring to enroll higher-risk participants in HIV prevention trials (English)

1 reference

27 July 2017

main subject

prevention of HIV/AIDS

0 references

1

Vera Halpern

1 reference

27 July 2017

Orikomaba Obunge

2

1 reference

27 July 2017

Folasade Ogunsola

3

1 reference

27 July 2017

Sakiru Otusanya

4

1 reference

27 July 2017

John Umo-Otong

5

1 reference

27 July 2017

Chin-Hua Wang

6

1 reference

27 July 2017

Neha Mehta

7

1 reference

27 July 2017

publication date

23 June 2009

1 reference

BMC Medical Research Methodology

27 July 2017

published in

1 reference

27 July 2017

volume

9

1 reference

27 July 2017

page(s)

44

1 reference

Creative Commons Attribution 2.0 Generic

27 July 2017

copyright license

start time

23 June 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

HIV incidence rates and risk factors for urban women in Zambia: preparing for a microbicide clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708194

Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708194

SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708194

SAVVY® (C31G) Gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708194

The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708194

Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708194

Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708194

A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708194

Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2288-9-44

UNAIDS Reference Group on estimates, modelling and projections--statement on the use of the BED assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19549331

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2288-9-44

1 reference

Dimensions Publication ID

27 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2288-9-44

9 September 2019

1 reference

27 July 2017

1 reference